Who is sponsoring NCT05328622?

NCT05328622 is sponsored by Transcendent International, LLC.

What drugs are being tested in NCT05328622?

Interventions in NCT05328622: Aqueduct Contingency Management Platform.

What condition does NCT05328622 study?

NCT05328622 studies Pregnancy Related.

Is NCT05328622 still recruiting?

NCT05328622 is currently completed. Last updated 2 January 2024.

Last reviewed 2024-01-02 · How we verify

NCT05328622

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rewarding Healthy Behaviors in Pregnancy and Postpartum

Completed NA Last updated 2 January 2024

What this trial tests

NA trial testing Aqueduct Contingency Management Platform in Pregnancy Related in 27 participants. Completed in 8 May 2023.

Timeline

12 July 2022

Primary endpoint
8 May 2023

8 May 2023

Quick facts

Lead sponsor	Transcendent International, LLC
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	27
Start date	12 July 2022
Primary completion	8 May 2023
Estimated completion	8 May 2023
Sites	1 location across United States

Drugs / interventions tested

Aqueduct Contingency Management Platform

Conditions studied

Pregnancy Related — all drugs for Pregnancy Related →

Sponsor

Transcendent International, LLC

Who can join

Adults 18 to 52, female only, with Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-arm pilot clinical trial with two primary research goals: 1. To test the efficacy of a software's ability to profile eligible individuals who decline participation in a clinical trial ("non-consenters") so that research staff may improve recruitment strategies for subsequent waves of potential participants. 2. To test the feasibility of using the software's contingency management program in a population of pregnant persons in their third trimester of pregnancy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pregnancy Related

Currently open trials in the same condition.

NCT05909761 — Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregn · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT07293559 — Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States · recruiting
NCT07518550 — Maternal and Fetal Electrocardiograms Separation Algorithm · NA · recruiting
NCT06965530 — Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05328622 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Transcendent International, LLC
Last refreshed: 2 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05328622.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing